Page last updated: 2024-08-23

paroxetine and nadp

paroxetine has been researched along with nadp in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chapple, S; Collins, C; Fairman, DA	1
Dalvie, DK; Frederick, KS; Kalgutkar, AS; Kelly, JM; Obach, RS; Smith, EB; Soglia, JR; Zhao, SX	1

Other Studies

2 other study(ies) available for paroxetine and nadp

Article	Year
Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation? Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:12 Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dihydralazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Models, Biological; NADP; Paroxetine; Pyrazines; Resveratrol; Stilbenes; Theophylline; Thiones; Thiophenes	2007
NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine. Chemical research in toxicology, 2007, Volume: 20, Issue:11 Topics: Biotransformation; Cytochrome P-450 CYP2D6 Inhibitors; Glutathione; Humans; Microsomes, Liver; NADP; Paroxetine; Quinones; Tritium	2007

Article

Year

Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?

Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:12

Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dihydralazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Models, Biological; NADP; Paroxetine; Pyrazines; Resveratrol; Stilbenes; Theophylline; Thiones; Thiophenes

2007

NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.

Chemical research in toxicology, 2007, Volume: 20, Issue:11

Topics: Biotransformation; Cytochrome P-450 CYP2D6 Inhibitors; Glutathione; Humans; Microsomes, Liver; NADP; Paroxetine; Quinones; Tritium

2007